Click below to read more research and studies involving the SprayShield™ adhesion barrier system.
Publications
White Papers
| Title |
Authors |
PDF |
| Safety Requirements for Abdominopelvic Adhesion Barriers: Part No. 389123 SS* |
P.K. Campbell, PhD; K. Howk |
 White Paper |
| Adhesion Prevention in General Surgery: A Next-Generation PEG Based Adhesion Barrier: Part No. 38912* |
R. Ferland, MD;
K. Howk;
P.K. Campbell, PhD |
 White Paper |
| Evaluation of SprayShield™ Adhesion Barrier System in a Porcine Model of Gynecological Surgery: Part No. 38911* |
R. Ferland, MD;
P.K. Campbell, PhD |
 White Paper |
| Technology Review of a Next-Generation Abdominopelvic Adhesion Barrier: Part No. 38912* |
Patrick K. Campbell, PhD;
Steven L Bennett, PhD |
 White Paper |
| The Adherence, Absorption Kinetics and Tissue Response of SprayShield™ Adhesion Barrier: Part No. 389121* |
Patrick K. Campbell, PhD;
Steven L Bennett, PhD;
David S. Garlick, DVM |
 White Paper |
| The Sprayshield™ Adhesion Barrier System Market Introduction: Clinical Trial Scenarios, Challenges, & Prospects: Part No. 05.09 LT-6000-062 |
Multiple |
 White Paper |
* The author(s) of this paper received funding from Covidien to compensate him/her for the work performed in connection with the study discussed in the article.

This product is not FDA approved for the US Market.
COVIDIEN, COVIDIEN with logo, Covidien logo and positive results for life are U.S. and/or internationally registered trademarks of Covidien AG. Other ™ marked brands are trademarks of a Covidien company. © 2010 Covidien. All rights reserved.